93 related articles for article (PubMed ID: 2491440)
1. Current status of radioimmunoglobulins in the treatment of human malignancy.
Order SE; Sleeper AM; Stillwagon GB; Klein TL; Leichner PK
Oncology (Williston Park); 1989 May; 3(5):115-20; discussion 122, 129-30. PubMed ID: 2491440
[TBL] [Abstract][Full Text] [Related]
2. Current status of radioimmunoglobulins in the treatment of human malignancy.
Order SE; Sleeper AM; Stillwagon GB; Klein JL; Leichner PK
Oncology (Williston Park); 1989 May; 3(5):115-20; discussion 122, 129-30. PubMed ID: 2577880
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunoglobulin therapy of cancer.
Order SE
Compr Ther; 1984 Jan; 10(1):9-18. PubMed ID: 6692670
[No Abstract] [Full Text] [Related]
4. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
[TBL] [Abstract][Full Text] [Related]
5. Radiolabeled antibodies: results and potential in cancer therapy.
Order SE; Sleeper AM; Stillwagon GB; Klein JL; Leichner PK
Cancer Res; 1990 Feb; 50(3 Suppl):1011s-1013s. PubMed ID: 2404579
[TBL] [Abstract][Full Text] [Related]
6. Current status of radioligand antibodies in the treatment of malignancy.
Maners AW; Sanders MM; Pappas AA
Ann Clin Lab Sci; 1988; 18(1):53-7. PubMed ID: 3281561
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. Brief overview of preclinical and clinical studies in the development of intraperitoneal radioimmunotherapy for ovarian cancer.
Meredith RF; Buchsbaum DJ; Alvarez RD; LoBuglio AF
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5643s-5645s. PubMed ID: 17875801
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric aspects of radiolabeled antibodies for tumor therapy.
Humm JL
J Nucl Med; 1986 Sep; 27(9):1490-7. PubMed ID: 3528417
[TBL] [Abstract][Full Text] [Related]
10. Overview of monoclonal antibodies in cancer therapy: present and promise.
Stern M; Herrmann R
Crit Rev Oncol Hematol; 2005 Apr; 54(1):11-29. PubMed ID: 15780905
[TBL] [Abstract][Full Text] [Related]
11. Targeting cancer with radiolabeled antibodies.
Goldenberg DM; Larson SM; Reisfeld RA; Schlom J
Immunol Today; 1995 Jun; 16(6):261-4. PubMed ID: 7662094
[No Abstract] [Full Text] [Related]
12. Antibody-based therapeutics in oncology.
Ross J; Gray K; Schenkein D; Greene B; Gray GS; Shulok J; Worland PJ; Celniker A; Rolfe M
Expert Rev Anticancer Ther; 2003 Feb; 3(1):107-21. PubMed ID: 12597355
[TBL] [Abstract][Full Text] [Related]
13. International Clinical Trials in Radiation Oncology. Isotopic immunotherapy: radiolabelled antibody.
Order SE
Int J Radiat Oncol Biol Phys; 1988; 14 Suppl 1():S77-81. PubMed ID: 3292485
[TBL] [Abstract][Full Text] [Related]
14. Technology evaluation: CC49 humanized radioimmunoconjugates, National Cancer Institute.
Sheikh N
Curr Opin Mol Ther; 2003 Aug; 5(4):428-32. PubMed ID: 14513687
[TBL] [Abstract][Full Text] [Related]
15. A proposal for a new direction to treat cancer.
Rose S
J Theor Biol; 1998 Nov; 195(1):111-28. PubMed ID: 9802954
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic applications of radiolabelled antibodies: current situation and prospects.
Larson SM; Carrasquillo JA; Reynolds JC; Hellstrom I; Hellstrom KE; Mulshine JC; Mattis LE
Int J Rad Appl Instrum B; 1986; 13(2):207-13. PubMed ID: 3490462
[No Abstract] [Full Text] [Related]
17. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
18. A Phase I study of combined modality (90)Yttrium-CC49 intraperitoneal radioimmunotherapy for ovarian cancer.
Alvarez RD; Huh WK; Khazaeli MB; Meredith RF; Partridge EE; Kilgore LC; Grizzle WE; Shen S; Austin JM; Barnes MN; Carey D; Schlom J; LoBuglio AF
Clin Cancer Res; 2002 Sep; 8(9):2806-11. PubMed ID: 12231520
[TBL] [Abstract][Full Text] [Related]
19. Systemic radiotherapy--the new frontier.
Order SE
Int J Radiat Oncol Biol Phys; 1990 May; 18(5):981-92. PubMed ID: 2189845
[TBL] [Abstract][Full Text] [Related]
20. Immunological approach to the treatment of acute lymphoblastic leukemia.
Bergolz VM; Kisljak NS; Eremeev VS; Rumjantzev AG; Akimova GV; Osipov SG
Neoplasma; 1980; 27(4):355-61. PubMed ID: 6935532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
